GLP-1 RAs and Hormonal Optimization: A Breakthrough for Weight Loss and Sexual Dysfunction with Semaglutide

Semaglutide: The Newest Gangbuster Weight Loss Solution
What is Semaglutide?

What is Semaglutide?  Semaglutide, the generic form of Wegovy® and Ozempic®, is a medicine you inject under the skin once a week. It belongs to the glucagon-like-peptide-receptor-agonist, GLPRA, class of medications initially approved for treating type II diabetics.[1] The dose starts low and increases over 16 weeks to reach the maximum amount used for weight loss. It helps reverse many problems that cause your body to gain weight by:

Making you feel full sooner, so you eat less. Helping your body use insulin better to turn sugar into energy instead of storing it as fat. Reducing your appetite by mimicking a hormone that targets areas of your brain.

As you lose weight, many other health issues can get better too. There’s some preliminary research, and my experience backs this up, that semaglutide may also help with alcohol cessation in those who are alcohol dependent.

Am I a Candidate for Semaglutide, Liraglutide or Tirzepatide?
You might be a candidate for these if you:
· Have an initial BMI of 30 or higher.
(See prior information on BMI, and notes below.)
· Have an initial BMI of 27 or higher and at least one weight-related condition like high blood pressure, high cholesterol, or type II diabetes.
· Men with 25% body fat or women with 30% body fat.
· Possess a waist-to-hip ratio over 1.2.
· There are also ethnic considerations allowed.
Discuss these with your doctor.
NOTE: These medications are especially helpful for those who have tried other weight loss methods without success, and these can be added to other programs, as clinically indicated.

Is Semaglutide Approved by the FDA?

Yes, the FDA approved Semaglutide for the chronic treatment of obesity in June 2021. It was already approved for treating type II diabetes. Some possible side effects include nausea, diarrhea or constipation, cramps, and bloating. These side effects are limited by gradually increasing the dose over 16 weeks. The others approved as of this writing for weight loss in this GLPRA drug class including Zepbound® (the same as Monjuaro®) and Saxenda®.

How Much Weight Can I Expect to Lose with Semaglutide, Liraglutide or Tirzepatide?

Saxenda (liraglutide):
7-8% potential weight lossWegovy (semaglutide):

15-16% potential weight loss

Zepbound (tirzepatide):
22-23% potential weight loss

At Unison Pro-Youth Institute, our Weight Loss Program includes:

Initial evaluation

 Consultation on lifestyle changes

Basic lab work

Supplements

Office phone number: 561-779-4558

Office email: info@unisonproyouth.com